These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 3533178

  • 21. Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapy.
    Zhang MJ, Baccarani M, Gale RP, McGlave PB, Atkinson K, Champlin RE, Dicke KA, Giralt S, Gluckman E, Goldman JM, Klein JP, Herzig RH, Masaoka T, O'Reilly RJ, Rozman C, Rowlings PA, Sobocinski KA, Speck B, Zwaan FE, Horowitz MM.
    Br J Haematol; 1997 Oct; 99(1):23-9. PubMed ID: 9359497
    [Abstract] [Full Text] [Related]

  • 22. Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemia.
    Kantarjian HM, Keating MJ, Walters RS, McCredie KB, Smith TL, Talpaz M, Beran M, Cork A, Trujillo JM, Freireich EJ.
    Cancer; 1986 Nov 01; 58(9):2023-30. PubMed ID: 3463397
    [Abstract] [Full Text] [Related]

  • 23. The evolving role of bone marrow transplantation in the treatment of chronic myelogenous leukemia.
    Delage R, Ritz J, Anderson KC.
    Hematol Oncol Clin North Am; 1990 Apr 01; 4(2):369-88. PubMed ID: 2182597
    [Abstract] [Full Text] [Related]

  • 24. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Gratwohl A, Hermans J, Goldman JM, Arcese W, Carreras E, Devergie A, Frassoni F, Gahrton G, Kolb HJ, Niederwieser D, Ruutu T, Vernant JP, de Witte T, Apperley J.
    Lancet; 1998 Oct 03; 352(9134):1087-92. PubMed ID: 9798583
    [Abstract] [Full Text] [Related]

  • 25. Identical-twin bone marrow transplants for leukemia.
    Gale RP, Horowitz MM, Ash RC, Champlin RE, Goldman JM, Rimm AA, Ringdén O, Stone JA, Bortin MM.
    Ann Intern Med; 1994 Apr 15; 120(8):646-52. PubMed ID: 8135448
    [Abstract] [Full Text] [Related]

  • 26. Bone marrow transplants in chronic myelogenous leukemia: an overview of determinants of survival.
    McGlave P.
    Semin Hematol; 1990 Jul 15; 27(3 Suppl 4):23-30. PubMed ID: 1695763
    [Abstract] [Full Text] [Related]

  • 27. Allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic or accelerated phase.
    Champlin R, Ho W, Arenson E, Gale RP.
    Blood; 1982 Oct 15; 60(4):1038-41. PubMed ID: 7052161
    [Abstract] [Full Text] [Related]

  • 28. Relapse in chronic myeloid leukemia after bone marrow transplantation: biomathematical modeling as a new approach to understanding pathogenesis.
    Vincent PC, Rutzen-Loesevitz L, Tibken B, Heinze B, Hofer EP, Fliedner TM.
    Stem Cells; 1999 Oct 15; 17(1):9-17. PubMed ID: 10215403
    [Abstract] [Full Text] [Related]

  • 29. Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group.
    Arcese W, Goldman JM, D'Arcangelo E, Schattenberg A, Nardi A, Apperley JF, Frassoni F, Aversa F, Prentice HG, Ljungman P.
    Blood; 1993 Nov 15; 82(10):3211-9. PubMed ID: 7693042
    [Abstract] [Full Text] [Related]

  • 30. Allogeneic bone marrow transplantation for acute leukaemia or chronic myeloid leukaemia in the fifth decade of life.
    Beelen DW, Quabeck K, Mahmoud HK, Schaefer UW, Becher R, Schmidt CG, Bamberg M, Quast U, Grosse-Wilde H, Haralambie E.
    Eur J Cancer Clin Oncol; 1987 Nov 15; 23(11):1665-71. PubMed ID: 3322846
    [Abstract] [Full Text] [Related]

  • 31. BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients.
    Verfaillie CM, Bhatia R, Miller W, Mortari F, Roy V, Burger S, McCullough J, Stieglbauer K, Dewald G, Heimfeld S, Miller JS, McGlave PB.
    Blood; 1996 Jun 01; 87(11):4770-9. PubMed ID: 8639848
    [Abstract] [Full Text] [Related]

  • 32. The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia.
    Miller CB, Rowlings PA, Zhang MJ, Jones RJ, Piantadosi S, Keating A, Armitage JO, Calderwood S, Harris RE, Klein JP, Lazarus HM, Linker CA, Sobocinski KA, Weisdorf D, Horowitz MM.
    Exp Hematol; 2001 Nov 01; 29(11):1336-46. PubMed ID: 11698130
    [Abstract] [Full Text] [Related]

  • 33. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK.
    Zhonghua Zhong Liu Za Zhi; 2006 Jul 01; 28(7):545-8. PubMed ID: 17147125
    [Abstract] [Full Text] [Related]

  • 34. Philadelphia chromosome-negative engraftment after autologous transplantation with granulocyte-macrophage colony-stimulating factor for chronic myeloid leukemia.
    Gladstone DE, Bedi A, Miller CB, Noga SJ, Griffin CA, Piantadosi S, Cagnoni PJ, Brodsky RA, Smith BD, Douglas TT, Shpall EJ, Jones RJ.
    Biol Blood Marrow Transplant; 1999 Jul 01; 5(6):394-9. PubMed ID: 10595817
    [Abstract] [Full Text] [Related]

  • 35. The reversal of myelofibrosis associated with chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Oblon DJ, Elfenbein GJ, Braylan RC, Jones J, Weiner RS.
    Exp Hematol; 1983 Aug 01; 11(7):681-5. PubMed ID: 6350032
    [Abstract] [Full Text] [Related]

  • 36. Significance of cytogenetic clonal evolution in chronic myelogenous leukemia.
    Majlis A, Smith TL, Talpaz M, O'Brien S, Rios MB, Kantarjian HM.
    J Clin Oncol; 1996 Jan 01; 14(1):196-203. PubMed ID: 8558198
    [Abstract] [Full Text] [Related]

  • 37. Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome-positive leukemias with the T315I mutation.
    Nicolini FE, Basak GW, Kim DW, Olavarria E, Pinilla-Ibarz J, Apperley JF, Hughes T, Niederwieser D, Mauro MJ, Chuah C, Hochhaus A, Martinelli G, DerSarkissian M, Duh MS, McGarry LJ, Kantarjian HM, Cortes JE.
    Cancer; 2017 Aug 01; 123(15):2875-2880. PubMed ID: 28387926
    [Abstract] [Full Text] [Related]

  • 38. The risk of residual molecular and cytogenetic disease in patients with Philadelphia-chromosome positive first chronic phase chronic myelogenous leukemia is reduced after transplantation of allogeneic peripheral blood stem cells compared with bone marrow.
    Elmaagacli AH, Beelen DW, Opalka B, Seeber S, Schaefer UW.
    Blood; 1999 Jul 15; 94(2):384-9. PubMed ID: 10397704
    [Abstract] [Full Text] [Related]

  • 39. Stem cell transplantation for chronic myeloid leukaemia: the role of infused marrow cell dose.
    Pocock C, Szydlo R, Davis J, de La Fuente J, Craddock C, Cwynarski K, Olavarria E, Rezvani K, Kanfer E, Apperley J, Goldman J.
    Hematol J; 2001 Jul 15; 2(4):265-72. PubMed ID: 11920259
    [Abstract] [Full Text] [Related]

  • 40. Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation.
    Sokal JE, Baccarani M, Tura S, Fiacchini M, Cervantes F, Rozman C, Gomez GA, Galton DA, Canellos GP, Braun TJ.
    Blood; 1985 Dec 15; 66(6):1352-7. PubMed ID: 3904870
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.